Impairment of cardiovascular autonomic pattern in obese adolescents with type 2 diabetes mellitus

Journal of Endocrinological Investigation

Volumn 33, Issue 8, 2010, Pages 539-543

  Cerutti, F ^a   Rabbia, F ^b   Rabbonei, I ^a   Bobbioi, A ^a   Ignaccolo, M G ^a   Greco, G ^a   Bertello, M C ^a   Mulatero, P ^b   Veglio, F ^b   Pacini, G ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CNR   (Italy)

Author keywords

Adolescents; Autonomic dysfunction; Insulin sensitivity; Obesity; Type 2 diabetes

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ARTERIAL WALL THICKNESS; ARTICLE; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR AUTONOMIC DYSFUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE VARIABILITY; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL FUNCTION; SCHOOL CHILD; SYMPATHETIC TONE; TRIACYLGLYCEROL BLOOD LEVEL; VAGUS TONE;

EID: 78049372141     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/bf03346644     Document Type: Article

References (30)

1. Imperatore G. Childhood obesity: is it time of action? Nutr Matab Cardiovasc Dis 2006, 16: 235-8.
2. Bloomgarden ZT. Type 2 Diabetes in the young: the evolving epidemic. Diabetes Care 2004, 27: 998-1010. (Pubitemid 38420231)
3. McQuaid S, O'Gorman DJ, Yousif O, et al. Early onset insulin resistant diabetes in obese Caucasians has features of typical type 2 diabetes, but 3 decades earlier. Diabetes Care 2005, 28: 1216-8. (Pubitemid 40616641)
4. American Diabetes Association. Type 2 Diabetes in children and adolescents. Pediatrics 2000, 105: 671-80.
5. Weiss R, Kaufman FR. Metabolic complications of childhood obesity. Diabetes Care 2008, 31: S310-6.
6. Yeckel CW, Taksali SE, Dziura J, et al. The normal glucose tolerance continuum in obese youth: evidence for impairment in β-cell function independent of insulin resistance. J Clin Endocrinol Metab 2005, 90: 747-54. (Pubitemid 40279191)
7. Grassi G, Dell'Oro R, Quarti-Trevano F, et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005, 48: 1359-65.
8. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999, 22: S5-19.
9. Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Research Clin Endocrinol Metab 2003, 17: 305-22. (Pubitemid 41128330)
10. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessment of insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001, 24: 539-48. (Pubitemid 32198427)
11. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA. nsulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 2006, 55: 1430-5.
12. Ahrén B, Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 2004, 150: 97-104.
13. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114: 555-76.
14. Berntson GG, Quigley KS, Jang JF, Boysen ST. An approch to artifact identification: application to heart period data. Psychophysiology 1990, 27: 586-98.
15. Task Force of the European Society of Cardiology and the North American Society of pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996, 93: 1043-65.
16. von Neumann J, Kent RH, Bellinson HR, Hart BI. The mean square successive difference. Ann Math Stat 1941, 12: 153-62.
17. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58: 1072-83. (Pubitemid 9091990)
18. Sinha R, Fish G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002, 346: 802-10.
19. Invitti C, Guzzaloni G, Gilardini L, Morabito F, Viberti G. Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care 2003, 26: 118-24.
20. Cerutti F, Sacchetti C, Bessone A, Rabbone I, Cavallo-Perin P, Pacini G. Insulin secretion and hepatic insulin clearance as determinants of hyperinsulinaemia in normotolerant grossly obese adolescents. Acta Paediatr 1998, 87: 1045-50. (Pubitemid 28476000)
21. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA. β-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 2004, 47: 31-9. (Pubitemid 38141937)
22. Arslanian SA, Bacha F, Saad R, Gungor N. Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth. Diabetes Care 2005, 28: 127-31.
23. Weiss R, Dziura JD, Burgert TS, Taksali SE, Tamborlane WV, Caprio S. Ethnic differences in beta cell adaptation to insulin resistance in obese children and adolescents. Diabetologia 2006, 49: 571-9.
24. Esler M, Straznicky N, Eikelis N, Masuo K, Lambert C, Lambert E. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006, 48: 787-96.
25. Rabbia F, Silke B, Contemo A, Grosso T, De Vito B, Rabbone I et al. Assessment of cardiac autonomic modulation during adolescent obesity. Obes Res 2003, 11: 541-8.
26. Lucini D, Cusumano G, Bellia A, et al; for the Linosa Study Group. Is reduced baroreflex gain a component of the metabolic syndrome? Insights from the LINOSA study. J Hypertens 2006, 24: 361-70.
27. Singh JP, Larson MG, Tsuji H, Evans JC, O'Donnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 1998, 32: 293-7. (Pubitemid 28376487)
28. La Rovere MT, Bigger JT, Marcus R, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction: ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction). Lancet 1998, 351: 478-84.
29. Grassi G. Role of the sympathetic nervous system in human hypertension. J Hypertens 1998, 16: 1979-87.
30. Avelar E, Cloward TV, Walker JM, et al. Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass. Hypertension 2007, 49: 34-9.